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ABSTRACT 
Objective: To develop a simple and accurate HPLC-DAD method for simultaneous determination, the content of major components: limonin, 
evodiamine, and rutaecarpine in Evodiae fructus and evaluation the quality of Evodiae fructus sold in markets. 
Methods: Open column chromatography was used to separate and purify rutaecarpine and evodiamine, the two major alkaloids from Evodiae 
fructus extract as a laboratory standard. Chromatographic separation was achieved using a Germini C18 column (150 mm × 4.6 mm I.D., 5 µm), 
detected at 210 nm. The mobile phase consisted of acetonitrile (A), methanol (B), and water (C). The validated method simultaneously determined 
alkaloid content in 40 batches of samples collected from markets in different regions of Vietnam.  
Results: In one-step purification, our method yielded 326 mg of rutaecarpine and 128 mg of evodiamine from 3.2 g of crude extract, with purities of 
98.9 and 98.5%, respectively. The structures of these compounds were identified using 1H NMR and 13C NMR. There was a significant correlation 
between alkaloid content and fruit size, with a Spearman correlation coefficient of>0.5 (p<0.001), and there was a large difference in alkaloid 
contents between three maturity degrees of the fruit. Open-mouth fruits and fruits with average sizes of 4 to 6 mm had the highest alkaloid 
contents, whereas closed-mouth fruits had the lowest. 
Conclusion: This study provided information on the standardization and quality control of evodiamine and rutaecarpine in Evodiae fructus, as well 
as a foundation for further pharmacological and toxicological studies. 
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The medicinal plants act as a rich source of natural products. Extraction 
and characterization of some active components from medicinal plants 
help in the discovery of new potent drugs [1, 2]. Evodiae fructus 
(Wuzhuyu in China, ngo-thu-du in Vietnam) is the dried, unripe fruit of 
Evodia rutaecarpa, which belongs to the family Rutaceae. It has been 
widely used in Vietnam as a traditional medicine for gastrointestinal 
disorders and post-partum hemorrhage and amenorrhea. Three of its 
major components are limonin, evodiamine, and rutaecarpine (fig. 1). 
Modern pharmacological studies have proved their various activities, 
such as anti-inflammatory [3, 4], antiobesity [5, 6], hypotensive, 
cardiotonic, central stimulative, vasodilatory, antithrombotic, and 
bronchoconstrictive activities [3, 7, 8]. 
Interestingly, the degree of maturity of Evodiae fructus is known to 
influence the content of its active ingredients [9]. Even the fruits 
from the same plant may have different degrees of maturity, and 
differ in size, color, shape, and smell. To control the quality of this 
fruit, the Chinese Pharmacopoeia detects its two major alkaloids, 
namely evodiamine and rutaecarpine. Several analytical assays for 
determining evodiamine and rutaecarpine contents have been 
reported, including liquid chromatography-tandem mass 
spectrometry (LC/MS/MS) [10, 11]. Although the two methods are 
highly sensitive and selective, their use is limited because of the high 
cost of their instrumentation. Therefore, this study aimed to develop 
a simple, rapid, and sensitive analytical method for quantifying 
biologically important components in Evodiae fructus, namely 
limonin, evodiamine, and rutaecarpine, to evaluate the quality of 
Evodiae fructus sold in markets. In this study, 40 batches of Evodiae 
fructus were collected and the contents of its two major alkaloids 
were simultaneously determined. Total evodiamine and 
rutaecarpine contents in different samples were analyzed to provide 
information on the reasonable use of Evodiae fructus. Open column 
chromatography was conducted to separate and purify of the two 
major alkaloids from Evodia rutaecarpa extract possessing the 
highest evodiamine and rutaecarpine contents. 
 
 
Fig. 1: Structures of limonin (1), evodiamine (2), and rutaecarpine (3) 
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MATERIALS AND METHODS 
Chemical and materials 
HPLC-grade acetonitrile and methanol were purchased from Merck 
Company (Darmstadt, Germany). Limonin (purity 98.47%), 
evodiamine (purity 99%), and rutaecarpine (purity 99%), were 
purchased from Sigma-Aldrich (Milwaukee, WI, USA).  
Forty fruits of Evodia rutaecarpa were collected from markets in 
different regions of Vietnam. The forty voucher specimen of Evodiae 
fructus was identified at Botany Department of Can Tho University 
of Medicine and Pharmacy and deposited at the Laboratory of Drug 
Control and Toxicology. The specimens were stored in sealed 
packages to avoid exposure to moisture and light. 
Preparation of standard 
Standard stock solutions of limonin (1 mg/ml), evodiamine (0.2 
mg/ml), and rutaecarpine (0.5 mg/ml) were prepared in 
acetonitrile. The standard working solution of each compound was 
prepared by diluting the stock solution with a mobile phase to 
suitable volumes of concentration.  
Preparation of sample solutions 
Forty batches of Evodiae fructus were pulverized into a powder, 
passed through a 0.3 mm sieve (30 meshes), and stored in a desiccator 
until use. Each powdered sample was accurately weighed (0.10 g), 
soaked in 80% ethanol for 10 min, and then extracted three times with 
40 ml 80% ethanol in an ultrasonic bath for 20 min. The extracted 
solution was filtered through an analytical filter paper and then 
evaporated to dryness by rotary vaporization under reduced pressure. 
The residue was suspended in 20 ml of CH2Cl2 and then successively 
partitioned twice with water (10 ml each). The CH2Cl2 extracts were 
combined and carefully evaporated to dryness in a vacuum. The dried 
residue was dissolved in 10 ml of mobile phase and injected into the 
HPLC system for quantitative analysis. All extracts were filtered 
through a 0.45 µm membrane filter into an HPLC vial and capped. 
Instrumentation and chromatographic conditions 
The experiment was carried out by a Hitachi HPLC L-2000 system 
(Hitachi, Japan) equipped with an L-2130 pump, L-2200 syringe, L-
2300 temperature control system, and L-2455 diode-array detector. 
Chromatographic separation was achieved using a Germini C18 column 
(150 mm × 4.6 mm I.D., 5 µm), detected at 210 nm. The mobile phase 
consisted of acetonitrile (A), methanol (B), and water (C). The gradient 
elution program was as follows: 0-18 min, linear gradient 40% A and 
5% B with a flow rate of 1 ml/min; 18-30 min, linear gradient 100% A 
with a flow rate of 1.2 ml/min. The injection volume was 10 µl. 
NMR spectroscopy was performed with a Brucker Advance III (500 
MHz; Brucker, Germany) operating at a probe temperature of 23±1 
°C. Tetramethyl silane (TMS) was used as reference (δ = 0.00 ppm). 
To mix the contents of the NMR tube, a Maxi Mix II mixer 
(Barnstead/Thermolyne, USA) was used. Spectra were recorded at 
500 MHz with CDCl3 (99.8 atom% D) containing 0.05% (v/v) TMS as 
an internal standard. 
Method validation 
The proposed method was validated under the guidance of the 
International Conference on Harmonization of Technical 
Requirements for the Registration of Pharmaceuticals for Human 
Use (ICH, 2005) [12]. The assays required to validate the method are 
as follows: system suitability, selectivity, linearity, limits of detection 
(LOD), limits of quantification (LOQ), accuracy, and precision assays.  
Isolation and purification of two major alkaloids in Evodiae 
fructus 
Preparation of crude sample 
After alkaloid contents were determined in the 40 batches of 
Evodiae fructus, fruits possessing the highest alkaloid contents were 
chosen for extraction, isolation, and purification of evodiamine and 
rutaecarpine. Each compound was isolated using open column 
chromatography. Each fraction was manually collected according to 
the thin layer of the chromatogram and evaporated under reduced 
pressure. The residues were dissolved in methanol for the 
subsequent HPLC analysis. 
HPLC analysis and identification of each fraction 
The crude extract and all fractions were analyzed by HPLC using a 
Germini C18 column (150 mm × 4.6 mm I.D., 5 µm). Acetonitrile-
methanol-water (15:45:40) was used as a mobile phase in isocratic 
mode, with a flow rate of 1.0 ml/min. The effluents were monitored 
at 225 nm by a photodiode array detector. The identification of each 
fraction was performed by 1H NMR and 13C NMR. 1H NMR and 13C 
NMR spectra were recorded on a Bruker Advance III (500 MHz; 
Brucker, Germany). 
Calculation 
According to the Chinese Pharmacopoeia, a high-quality Evodiae 
fructus should contain at least 0.15% of total evodiamine and 
rutaecarpine contents. The total content of each compound was 
calculated by the following formula:  
Content (%) of analyte WDVC 10000/)**(=  
Where:  
C = the concentration (mg/l) of an analyte in a test solution, 
D = dilution factor, if any, 
V = the final make-up volume (ml) of the test solution, 
W = the weight (g) of the sample used to prepare the test solution. 
RESULTS 
Optimization of chromatographic conditions 
Limonin, evodiamine, and rutaecarpine were identified by their 
retention times (tR) and by co-injection with standards. The 
wavelength used to detect limonin, evodiamine, and rutaecarpine in 
Evodiae fructus was selected by using photodiode-array detection 
(DAD). The maximum number and height of the three peaks were 
obtained and the baseline of the chromatogram was stable at 210 
nm. Therefore, 210 nm was chosen as a detection wavelength. The 
peak purity of the three compounds in the samples was 99.9%, 
which was the spectrum overlaying the graphs of three-point purity 
detection. Optimization of chromatographic conditions was 
performed by using a Gemini RP-C18 with different compositions of 
mobile phases [methanol-water (1), acetonitrile-water (2), and 
acetonitrile-methanol-water (3) systems] and a different ratio of 
solvents in isocratic mode. The results showed that with system 1, 
limonin was eluted much more rapidly (2-3 min) than evodiamine 
and rutaecarpine (50 min). 
In contrast, elution with system 2 produced a good resolution of the 
three components but with short analysis time (under 8 min), which 
proves inconvenient for herbal matrices. Good resolution, baseline, 
sharp and symmetrical peaks, and favorable retention time were 
obtained by using system 3. The mobile phase was acetonitrile–
methanol-water in the ratio of 40:5:55, and the retention times of 
limonin, evodiamine, and rutaecarpine were 8.1, 12.5, and 15.5 min, 
respectively. However, because of the polar impurity of compounds 
in the extract solution, we shortened the analysis time by using 
gradient elution. The representative chromatogram of the sample 
and standard (fig. 2) showed that limonin, evodiamine, and 
rutaecarpine were eluted with highly symmetrical peaks under the 
conditions. The analysis time was 30 min. 
Method validation 
System suitability 
System suitability was tested by performing six replicate injections 
and determining the theoretical plate number (N), resolution (Rs), 
symmetry factor (As), and repeatability (RSD of retention time and 
area) of the analyte of interest. The % RSD values of area and 
retention time were less than 2%, indicating the precise analysis of 
limonin, evodiamine, and rutaecarpine by this system. All results 
showed that the proposed method met the requirements. 
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Selectivity 
Method selectivity was tested by using HPLC to compare the 
retention time of each standard reference compound with that of the 
peaks of Evodiae fructus extract. The HPLC method was able to 
distinguish limonin, evodiamine, and rutaecarpine from other 
constituents in Evodiae fructus (flavonoids, quinolone alkaloids, 
etc.). There was no interference with the peaks of limonin, 
evodiamine, and rutaecarpine in Evodiae fructus. Therefore, the peak 
purity of the three compounds in the sample was 99.9%, as obtained 
from the spectrum overlaying the graphs of three-point purity 




Fig. 2: Representative HPLC chromatograms of mixed standards (a) and Evodiae fructus extract (b) at 210 nm 
 
 
Fig. 3: UV-vis spectrum between standard and extract at their retention time: (a) limonin, (b) evodiamine, (c) rutaecarpine, and (d) 3 D 
spectrum of Evodiae fructus extraction 
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Precision, linearity, limits of detection, and limits of 
quantification 
The results of the regression equation and squared correlation 
coefficients (r2) are summarized in table 1. The LOD of the three 
constituents was 0.0625 μg/ml. The LOQ of limonin and 
rutaecarpine was 0.125 μg/ml, whereas that of evodiamine was 0.2 
μg/ml. The RSDs of intra-day and inter-day were 4.81–6.07, 2.15–
6.79, and 6.01-6.13% for limonin, evodiamine, and rutaecarpine, 
respectively.
 
Table 1: Linear regression data, LOD and LOQ, precision of the HPLC method for determination of limonin, evodiamine and rutaecarpine 
Parameter Limonin Evodiamine Rutaecarpine 
Regression equationa y = 51262x-177671 y = 268015x-109314 y = 324051x-875002 
Linearity range (µg/ml), n=8 5-200 5-100 5-200 
r2 0.9977 0.9959 0.9967 
LOD (µg/ml), n=3 0.0625 0.0625 0.0625 
LOQ (µg/ml), n=3 0.125 0.2 0.125 
Precision (intra-day, % RSD, n=6) 4.81 2.15 6.01 
Precision (inter-day, % RSD, n=3) 6.07 6.79 6.13 
a= y is the concentration of the analyte (μg/ml), and x is the peak area, n=number of determination, % RSD = % Relative standard deviation 
 
Accuracy 
Table 2 shows a summary of extraction recovery in Evodiae fructus 
samples. The developed method had good accuracy with an overall 
recovery of 102.73, 101.58, and 103.34% for limonin, evodiamine, 
and rutaecarpine, respectively, with % RSD of less than 5% for the 
analytes. Considering the results of the recovery test, the method 
was deemed to be accurate. 
 
Table 2: Recoveries for the assay of the investigated compounds in Evodiae fructus 
Analytes Sample Concentration (µg/ml) Recovery  Mean recovery RSD (%) 
Original Added Found (%) n=9 n=9 
Limonin S1a 56.11 50 106.68 101.14   
 S2b 56.11 60 118.36 103.76 102.73±5.12 4.98 
 S3c 56.11 70 128.42 103.30   
 S1a 19.87 15 34.88 100.06   
Evodiamine S2b 19.87 20 39.86 99.94 101.58±4.51 4.44 
 S3c 19.87 25 46.05 104.73   
 S1a 20.64 15 36.01 102.46   
Rutaecarpine S2b 20.64 20 41.09 102.27 103.34±3.91 3.78 
 S3c 20.64 25 46.96 105.30   
Recovery (%) = ((found−original)/added) ×100., aThe samples added known amounts of standards at low level (80% of the known amounts)., bThe 
samples added known amounts of standards at medium level (same as the known amounts)., cThe samples added known amounts of standards at 
high level (120% of the known amounts), % RSD = % Relative standard deviation 
 
Quality evaluation of Evodiae fructus in markets 
Evodiamine and rutaecarpine contents in 40 samples of Evodiae 
fructus are summarized in table 3 and 4. Data are expressed as % 
(grams per 100 gram) of dry weight. The results showed a 
relationship between alkaloid contents and fruit size (fig. 4). The 
contents of the two major alkaloids were also significantly 
correlated with maturity degrees, as shown in fig. 5. 
 
Table 3: Correlations between alkaloid contents and fruit size 
Fruit size (mm) N Mean of alkaloids content (%) Test 
2 9 0.1744  
Spearman parameter r=0.597 
p<0.001  
3 9 0.2024 
4 3 0.4179 
5 6 0.9539 
6 8 0.7214 
7 3 0.3624 
8 2 0.3124 
Total 40 0.44629  
N= number of samples 
 
Table 4: Correlations between alkaloid contents and maturity degree 
Maturity degree N Content Kruskal wallis test χ 2. p 
mean±SD Median 
Closed mouth fruit 12 0.18716±1156.4 0.1445 χ 2= 11.1 
p = 0.004 Open-mouth fruit 19 0.65173±7075.9 0.3875 
Large mouth fruit 9 0.3581±2036.7 0.2892 
Total 40 0.44629±5351.4 3013  
N= number of samples, SD=Standard deviation 
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Fig. 4: Correlation of alkaloids content of Evodiae fructus samples and their fruit size 
 
 
Fig. 5: Correlation of alkaloids content of Evodiae fructus samples and their maturity degrees 
 
Isolation and purification of rutaecarpine and evodiamine 
Open column chromatography and purification conditions 
A series of experiments were performed to optimize the mobile phase 
solvent system for the proposed column separation method. 
Chloroform-methanol, chloroform-ethyl acetate, and n-hexane-ethyl 
acetate were tested as mobile phase solvents. When ethyl acetate-
methanol was used, the target compounds mainly co-elute. By using 
chloroform-ethyl acetate, the elution was improved, but target 
compounds and nonpolar impurities were not separated. Thus, 
chloroform-methanol and chloroform-ethyl acetate were unsuitable to 
separate and purify the alkaloids in Evodiae fructus. In contrast, a 
mixture of n-hexane and ethyl acetate improved the fraction separation. 
The first fraction was purified by washing with cool n-hexane and a pure 
second fraction was obtained through precipitation with chloroform. 
Two kinds of alkaloids were obtained in the one-step purification, 
yielding 326 mg rutaecarpine (I) and 128 mg of evodiamine (II) from 
3.2 g crude sample. The purities of the two compounds were 98.9 and 
98.5% respectively, as determined by HPLC. The chromatograms and 
UV spectra of these compounds are shown in fig. 6. 
The structural identification 
The chemical structure of each fraction was identified according to 
its 1H NMR, 13C NMR and ESI-MS data:  
Fraction (I): 1H-NMR (500 MHz, CDCl3) δ ppm: 9.51 (br s. 1H. NH); 
8.32 (d. 1H; J=7; H19); 7.70 (m. 1H. H17); 7.63 (m. 1H; H16); 7.42 
(m. 1H; H9); 7.36 (m. 1H; H12); 7.31 (m. 1H; H18); 7.25 (s. 1H; 
H11); 7.17 (m. 1H; H10); 4.59 (t. 2H; H5); 3.23 (t. 2H; H6). 13C-
NMR (125 MHz, CDCl3) δ ppm: 127.2 (C-2), 145.4 (C-3), 41.1 (C-5), 
19.7 (C-6), 118.4 (C-7), 125.6 (C-8), 120.6 (C-9), 120.1 (C-10), 
125.6 (C-11), 112.1 (C-12), 138.3 (C-13), 147.5 (C-15), 126.2 (C-
16), 134.3 (C-17), 127.1 (C-18), 126.6 (C-19), 121.1 (C-20), 162.0 
(C-21). ESI-MS m/z 288.1131 calculated for C18H13N3O. According 
to the data obtained by Liu et al., fraction I corresponded to 
rutaecarpine [14]. 
Fraction (I): 1H-NMR (500 MHz, CDCl3) δ ppm: 8,24 (br s, 1H, 
NH); 8,12 (dd, 1H; J=6.5; H19); 7,59 (d, 1H; J=7.5; H9); 7,49 (m, 1H, 
H17); 7,41 (d, 1H, J=8; H12); 7,25 (m, 2H; H11, H16); 7,19 (m, 2H; 
H10, H18); 5,92 (s, 1H; H3); 4,87 (m, 1H; H5); 3,29 (m, 2H; H5); 2,96 
(m, 2H; H6); 2,505 (s, 3H; N-CH3). 13C-NMR (125 MHz, CDCl3) δ 
ppm: 129.0 (C-2), 68.8 (C-3), 39.5 (C-5), 20.1 (C-6), 113.7 (C-7), 
126.3 (C-8), 118.9 (C-9), 123.1 (C-10), 124.1 (C-11), 111.3 (C-
12), 136.7 (C-13), 150.6 (C-15), 122.4 (C-16), 133.1 (C-17), 123.8 
(C-18), 128.2 (C-19), 120.0 (C-20), 164.7 (C-21), 37.2 (N CH3). 
ESI-MS m/z 303.1464 calculated for C19H17N3O. In accordance 
with the data obtained by Liu et al., fraction II corresponded to 
evodiamine [14]. 
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Fig. 6: HPLC purity test of two fractions collected from Evodiae fructus extraction, fraction (I): rutaecarpine, fraction (II) evodiamine 
 
DISCUSSION 
Contents of the three major components in Evodiae fructus extract 
could easily be determined within 30 min. All calibration curves 
showed good linear regression (r2>0.99), with RSDs of intra-day and 
inter-day of approximately 6%. The overall recovery of the analytes 
was in the range of 101.58 to 103.34% with % RSD of less than 5%; 
thus, the proposed method was deemed to be precise and accurate. 
Zhao et al. developed an LC method for determining 
dehydroevodiamine, wuchuyuamide-I, 5-hydroxyrutaecarpine, 14-
formyldihydrorutaecarpine, evodiamine, and rutaecarpine contents; 
however, the method requires a long analysis time of 70 min and 
complicated mobile phase consisting of methanol, acetonitrile, and 
phosphoric acid-triethylamine-buffer solution [13]. In this study, we 
conducted a simple chromatography using popular solvents 
commonly available in laboratories, which required only a short 
time (30 min) to measure the amount of the three major 
components in Evodiae fructus. 
The validated method was successfully applied to simultaneously 
determine the contents of the two major alkaloids of Evodiae fructus 
in 40 samples collected from markets in different regions of 
Vietnam. As shown in table 3, alkaloid concentrations were the 
highest in the open-mouth fruits, followed by those in the large-
mouth fruits and closed-mouth fruits, with χ 2= 11.1 and p = 0.004, 
as analyzed by the Kruskal-Wallis test. Closed-mouth fruits showed 
low contents of the two major alkaloids. In this group, 8 out of 12 
samples showed evodiamine and rutaecarpine contents of less than 
0.15%. In contrast, in open-mouth fruits, 19 samples showed high 
evodiamine and rutaecarpine contents. For instance, sample C03 
showed total evodiamine and rutaecarpine contents of up to 3%. 
Interestingly, in large mouth-fruits (similar to open-mouth fruits 
except that their ovaries are split completely into five 
compartments), 9 samples showed uniformly high evodiamine and 
rutaecarpine contents. Similarly, as shown in table 4 and fig. 6, the 
highest alkaloid concentrations were observed in the fruit group 
with an average size of 4 to 6 mm, followed by those with big sizes of 
7 to 8 mm and small sizes of 1 to 3 mm. The differences were 
significant, with a Spearman correlation coefficient of r>0.5 
and p<0.001. The results were useful as a guide for choosing Evodiae 
fructus base on the fruit’s degree of maturity. 
In a one-step purification of 3.2 g crude extract, we obtained 326 
and 128 mg of rutaecarpine (98.9% purity) and evodiamine (98.5% 
purity), respectively. Liu et al. used high-speed counter-current 
chromatography with a two-phase solvent system to isolate and 
purify five alkaloids, including 18 mg of evodiamine and 9 mg of 
rutaecarpine (purity of 98.4%), from 6.2 g crude sample [14]. In 
comparison with our results, we can conclude that our method was 
effective and economical. It can be implied that these pure alkaloids 
can be used as a standard to control the quality of Evodiae fructus in 
Vietnam. Currently, the Vietnamese Pharmacopoeia uses total oil 
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content to evaluate the quality of this fruit. Our results provided an 
option to use natural standard compounds, namely evodiamine and 
rutaecarpine, to control the quality of Evodiae fructus in the market.  
CONCLUSION 
In summary, this study described the development, validation, and 
application of an HPLC method for determining limonin, evodiamine, 
and rutaecarpine contents in Evodiae fructus using Germini C18 
column. The relatively simple sample preparation, together with the 
short HPLC run time (30 min), proved that the present method was 
useful for routine quantitative analysis and quality control of 
limonin, evodiamine, and rutaecarpine, the major components in 
Evodiae fructus. This method was satisfactory in terms of accuracy, 
precision, sensitivity, and reproducibility. The method was 
successfully applied to analyze 40 batches of samples collected from 
markets, and the results showed that alkaloid contents were related 
to fruit size and fruit maturity degree. The highest alkaloid 
concentrations were observed in fruits with an average size of 4 to 6 
mm, and open-mouth fruits. The proposed method was shown to be 
useful as a guide for choosing Evodiae fructus base on its maturity 
degree. Next, fruits possessing the highest alkaloid contents were 
chosen for isolation and yielded 326 mg of rutaecarpine and 128 mg 
of evodiamine from 3.2 g crude sample. The purity was 98.9 and 
98.5%, respectively, as determined by HPLC. This study sheds light 
on the standardization and quality control of evodiamine and 
rutaecarpine. 
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